Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="DEWIT, O" or (type exact bookEditor and editor="DEWIT, O")

Add to list
Profile of pediatric Crohn's disease in Belgium

E De Greef, JM Mahachie John, I Hoffman, F Smets, Stephanie Van Biervliet (UGent) , M Scaillon, B Hauser, I Paquot, P Alliet, W Arts, et al.

(2013) JOURNAL OF CROHNS & COLITIS. 7(11). p.e588-e598
Add to list
- Journal Article
- A1
- open access
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

Martine De Vos (UGent) , O Dewit, G D'Haens, F Baert, F Fontaine, S Vermeire, D Franchimont, T Moreels, D Staessen, L Terriere, et al.

(2012) JOURNAL OF CROHNS & COLITIS. 6(5). p.557-562
Add to list
- Conference Paper
- C3
- open access
Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis

Martine De Vos (UGent) , J Jahnsen, J Vandervoort, G D'haens, O Dewit, E Louis, D Franchimont, F Baert, R Torp, P Potvin, et al.

(2012) JOURNAL OF CROHNS & COLITIS. 6(suppl. 1). p.S4-S4
Add to list
Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn’s disease

E De Greef, I Hoffman, G D’Haens, Stephanie Van Biervliet (UGent) , F Smets, M Scaillon, O Dewit, Harald Peeters (UGent) , I Paquot, P Alliet, et al.

(2012) ACTA GASTRO-ENTEROLOGICA BELGICA. 75(4). p.425-431
Add to list
- Conference Paper
- C3
- open access
Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease

E De Greef, I Hoffman, G D'haens, Stephanie Van Biervliet (UGent) , F Smets, M Scaillon, O Dewit, Harald Peeters (UGent) , I Paquot, P Alliet, et al.

(2012) ESPGHAN Update, Abstracts.

← Previous

Academic Bibliography

Profile of pediatric Crohn's disease in Belgium

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis

Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn’s disease

Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease

Contents

Support

Contact